Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Accentia BioPharmaceuticals, Inc. > News item |
Accentia looks to extend exclusive plan-filing period to Jan. 22
By Lisa Kerner
Charlotte, N.C., Jan. 8 - Accentia Biopharmaceuticals, Inc. wants to extend its exclusive right to file a plan of reorganization to Jan. 22 from Jan. 8, according to a Friday filing with the U.S. Bankruptcy Court for the Middle District of Florida.
Specifically, the exclusive plan-filing period would be extended to Jan. 22 from Jan. 8, and the solicitation period would be extended to March 31 if the plan is filed by Jan. 22.
Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10, 2008. Its Chapter 11 case number is 08-17795.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.